0.668
0.02 (2.38%)
| Previous Close | 0.652 |
| Open | 0.658 |
| Volume | 7,641 |
| Avg. Volume (3M) | 1,473,707 |
| Market Cap | 14,322,165 |
| Price / Sales | 386.20 |
| 52 Weeks Range |
| Operating Margin (TTM) | -11,739.09% |
| Diluted EPS (TTM) | -0.060 |
| Quarterly Revenue Growth (YOY) | -87.00% |
| Current Ratio (MRQ) | 0.270 |
| Operating Cash Flow (TTM) | -1.24 M |
| Levered Free Cash Flow (TTM) | -1.25 M |
| Return on Assets (TTM) | -61.74% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Bullish | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Bearish | |
| Stock | Cuprina Holdings (Cayman) Limit | - | - |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | 1.13 |
|
Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 28 Nov 2025 | Announcement | Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency |
| 18 Nov 2025 | Announcement | Cuprina forms Joint Venture Company with Aiodine Laboratory to Develop and Market Novel Iodine-based Solution as New Wound Care Therapy |
| 27 Oct 2025 | Announcement | Cuprina Signs MOU with Singapore Biowaste Solutions to Integrate Medical Waste Management Technologies |
| 06 Oct 2025 | Announcement | Cuprina to Present Live, Answer Questions, at Skyline Signature Series™ on October 8th, 2025, at 11:00 AM ET |
| 09 Sep 2025 | Announcement | Cuprina Secures Exclusive Rights to Southeast Asia’s First UNIDO/GEF- Demonstrated Medical Waste Recycling Technology |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |